118 related articles for article (PubMed ID: 28445956)
1. RHBDD1 upregulates EGFR via the AP-1 pathway in colorectal cancer.
Miao F; Zhang M; Zhao Y; Li X; Yao R; Wu F; Huang R; Li K; Miao S; Ma C; Ju H; Song W; Wang L
Oncotarget; 2017 Apr; 8(15):25251-25260. PubMed ID: 28445956
[TBL] [Abstract][Full Text] [Related]
2. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
3. Rhomboid domain containing 1 inhibits cell apoptosis by upregulating AP-1 activity and its downstream target Bcl-3.
Ren X; Song W; Liu W; Guan X; Miao F; Miao S; Wang L
FEBS Lett; 2013 Jun; 587(12):1793-8. PubMed ID: 23669365
[TBL] [Abstract][Full Text] [Related]
4. Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway.
Song W; Liu W; Zhao H; Li S; Guan X; Ying J; Zhang Y; Miao F; Zhang M; Ren X; Li X; Wu F; Zhao Y; Tian Y; Wu W; Fu J; Liang J; Wu W; Liu C; Yu J; Zong S; Miao S; Zhang X; Wang L
Nat Commun; 2015 Aug; 6():8022. PubMed ID: 26300397
[TBL] [Abstract][Full Text] [Related]
5. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
[TBL] [Abstract][Full Text] [Related]
6. Lentivirus-mediated knockdown of rhomboid domain containing 1 inhibits colorectal cancer cell growth.
Han J; Bai J; Yang Y; Yin H; Gao W; Lu A; Liu F; Ge H; Liu Z; Wang J; Zhong L
Mol Med Rep; 2015 Jul; 12(1):377-81. PubMed ID: 25695376
[TBL] [Abstract][Full Text] [Related]
7. Exosome-related multi-pass transmembrane protein TSAP6 is a target of rhomboid protease RHBDD1-induced proteolysis.
Wan C; Fu J; Wang Y; Miao S; Song W; Wang L
PLoS One; 2012; 7(5):e37452. PubMed ID: 22624035
[TBL] [Abstract][Full Text] [Related]
8. SH3GL1 inhibition reverses multidrug resistance in colorectal cancer cells by downregulation of MDR1/P-glycoprotein via EGFR/ERK/AP-1 pathway.
Guan H; Zhao P; Dai Z; Liu X; Wang X
Tumour Biol; 2016 Sep; 37(9):12153-12160. PubMed ID: 27220321
[TBL] [Abstract][Full Text] [Related]
9. TOPK promotes lung cancer resistance to EGFR tyrosine kinase inhibitors by phosphorylating and activating c-Jun.
Li Y; Yang Z; Li W; Xu S; Wang T; Wang T; Niu M; Zhang S; Jia L; Li S
Oncotarget; 2016 Feb; 7(6):6748-64. PubMed ID: 26745678
[TBL] [Abstract][Full Text] [Related]
10. microRNA-375 inhibits colorectal cancer cells proliferation by downregulating JAK2/STAT3 and MAP3K8/ERK signaling pathways.
Wei R; Yang Q; Han B; Li Y; Yao K; Yang X; Chen Z; Yang S; Zhou J; Li M; Yu H; Yu M; Cui Q
Oncotarget; 2017 Mar; 8(10):16633-16641. PubMed ID: 28186962
[TBL] [Abstract][Full Text] [Related]
11. Cortactin promotes colorectal cancer cell proliferation by activating the EGFR-MAPK pathway.
Zhang X; Liu K; Zhang T; Wang Z; Qin X; Jing X; Wu H; Ji X; He Y; Zhao R
Oncotarget; 2017 Jan; 8(1):1541-1554. PubMed ID: 27903975
[TBL] [Abstract][Full Text] [Related]
12. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
13. Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer.
Leupold JH; Asangani I; Maurer GD; Lengyel E; Post S; Allgayer H
Mol Cancer Res; 2007 May; 5(5):485-96. PubMed ID: 17510314
[TBL] [Abstract][Full Text] [Related]
14. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C
Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543
[TBL] [Abstract][Full Text] [Related]
15. Transactivation of the EGFR by AP-1 is induced by Helicobacter pylori in gastric cancer.
Ashktorab H; Daremipouran M; Wilson M; Siddiqi S; Lee EL; Rakhshani N; Malekzadeh R; Johnson AC; Hewitt SM; Smoot DT
Am J Gastroenterol; 2007 Oct; 102(10):2135-46. PubMed ID: 17617207
[TBL] [Abstract][Full Text] [Related]
16. Asporin enhances colorectal cancer metastasis through activating the EGFR/src/cortactin signaling pathway.
Wu H; Jing X; Cheng X; He Y; Hu L; Wu H; Ye F; Zhao R
Oncotarget; 2016 Nov; 7(45):73402-73413. PubMed ID: 27705916
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of epidermal growth factor-mediated oncogenic transformation by sialidase NEU3 leading to Src activation.
Yamamoto K; Takahashi K; Shiozaki K; Yamaguchi K; Moriya S; Hosono M; Shima H; Miyagi T
PLoS One; 2015; 10(3):e0120578. PubMed ID: 25803810
[TBL] [Abstract][Full Text] [Related]
18. HDAC inhibitors suppress c-Jun/Fra-1-mediated proliferation through transcriptionally downregulating MKK7 and Raf1 in neuroblastoma cells.
He W; Wu Y; Tang X; Xia Y; He G; Min Z; Li C; Xiong S; Shi Z; Lu Y; Yuan Z
Oncotarget; 2016 Feb; 7(6):6727-47. PubMed ID: 26734995
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of CDC27 inhibits the proliferation of colorectal cancer cells via the accumulation of p21Cip1/Waf1.
Qiu L; Wu J; Pan C; Tan X; Lin J; Liu R; Chen S; Geng R; Huang W
Cell Death Dis; 2016 Jan; 7(1):e2074. PubMed ID: 26821069
[TBL] [Abstract][Full Text] [Related]
20. Tristetraprolin induces cell cycle arrest in breast tumor cells through targeting AP-1/c-Jun and NF-κB pathway.
Xu L; Ning H; Gu L; Wang Q; Lu W; Peng H; Cui W; Ying B; Ross CR; Wilson GM; Wei L; Wold WS; Liu J
Oncotarget; 2015 Dec; 6(39):41679-91. PubMed ID: 26497679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
